
The response to the pandemic had a focus group of young people concerned for not only themselves but others as well.
Rachel is a longtime contributor to Contagion, HCP Live and MD Magazine. She frequently covers C diff, coronavirus and other infectious diseases.

The response to the pandemic had a focus group of young people concerned for not only themselves but others as well.

Putting these findings in the context of the ongoing coronavirus crisis was especially important, the study authors said.

The study authors noted that Haemophilus influenza type b was alone in lower protective rates in the preterm infants after the booster shot compared to healthy infants.

The study retrospectively observed more than 800 patients in the Maryland and Washington, D.C. area during March and April.

Adults with confirmed COVID-19 were twice as likely as control participants to report having dined out at a restaurant in the 14 days prior to symptom onset.

The time to first antibiotic dose is an important step of this new program, however it may require an audit after review according to a new study.

Obesity was a risk factor for intubation and death from COVID-19 for adults under the age of 65.

Study authors collected more than 7000 S. pneumoniae isolates between 2009 and 2017.

As the hepatitis C population ages, they experience more age-related mortality causes; direct-acting antiviral therapy may help, a new study finds.

Here is a compilation of the COVID-19 vaccine candidates that have achieved FDA Emergency Use Authorization, other approvals, and are in phases 1-3.

Nearly half of all the people living with HIV are over the age of 50, so age-related comorbidities are becoming a factor.

More COVID-19 patients were hospitalized with MIS-C in April than in March, a study finds.

A model including clinical symptom reports, Internet searches, and emergency room data predict influenza hospitalizations better in affluent vs. poorer communities.

Following an outbreak of both COVID-19 and H1N1 influenza, Parisian hospital admissions for Kawasaki disease increased.

While household transmission of C diff infection is low, there was increased incidence after a familial exposure.

Four human coronavirus infection rates were relatively consistent among all age groups older than 4 years, the study also found.

Pregnant women with COVID-19 typically experienced symptoms in their second and third trimester, a new study shows.

The novel integrase inhibitor was well tolerated in adult non-HIV infected population.

About two-thirds of patients that reported loss of smell associated with viral infection actually had confirmed anosmia after objective olfactory testing.

An eventual COVID-19 vaccination should be prepared to face obstacles before distribution, so the groundwork for factual information dissemination should begin now.

While COVID-19 may have impacted flu-like illness reporting, the CDC estimates there were between 24,000-62,000 related deaths this year.

Experts argue that though public officials may liken coronavirus to "just another flu," the true numbers show a stark difference.

Investigators reviewed 8 studies which had various treatment duration, number of antibacterial courses, and definitions of response to treatment.

Clinicians should be wary of risk for depression, anxiety, fatigue, PTSD, and, potentially, rare neuropsychiatric syndromes, in post-coronavirus patients.

While not without its challenges, converting a pediatric intensive care unit to care for adult novel coronavirus patients was the right decision for the Mass General Hospital for Children.

Gram-negative bacteria can cause infections, are resistant to multiple drugs, and are increasingly resistant to most available antibiotics, the CDC says.

There may be more fatalities linked to COVID-19 in Los Angeles County than previously thought.

Investigators compare infection rates among heathcare workers throughout different coronavirus epidemics, including SARS, COVID-19, and MERS.

Some hepatitis C virus treatments for pediatric patients may be cost-effective.

Treating severe COVID-19 patients with lopinavir-ritonavir did not have any significant effect compared to standard-care control patients.